Indeed, it was found that CD36 (a phagocytic marker in macrophages) was reduced post-myocardial infarction in animals treated with an MMP-9 inhibitor but increased post-myocardial infarction in MMP-9 knockout mice [70]. This evidence concerns the gene CD36 and myocardial infarction.